Insider · CIK 0001666011
Khalil Barrage
Files at PTIX (Protagenic Therapeutics, Inc.\new). First filing -, latest -.
In brief
Khalil Barrage files SEC Form 4 as director at PTIX (Protagenic Therapeutics, Inc.\new). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Khalil Barrage has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 25, 2024 | PTIX Protagenic Therapeutics, Inc.\new | AGrant or award PTIX Common stock Optionsderivative | +22,500 | $1.74 | $39k | 22,500 | Mar 29, 2024 |
Questions about Khalil Barrage
Answered from the filings on this page, as of the latest one.
Is Khalil Barrage buying or selling?
Khalil Barrage has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Khalil Barrage's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Khalil Barrage has 0.
Where does Khalil Barrage file Form 4?
Khalil Barrage has filed Form 4 at PTIX (Protagenic Therapeutics, Inc.\new). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.